What are Down Syndrome Tests?
Down Syndrome Tests are a group of screening and diagnostic tests used to determine whether a fetus or newborn may have Down syndrome, a genetic condition caused by having an extra copy of chromosome 21. Testing can be performed during pregnancy or after birth. Prenatal screening tests estimate the likelihood that a fetus has Down syndrome, while diagnostic tests can confirm whether the condition is present.
Common Down syndrome tests include:
Cell-Free DNA (cfDNA) Screening: A blood test that analyses small fragments of fetal DNA circulating in the pregnant person’s blood.
First-Trimester Screening: Combines a blood test with an ultrasound measurement called nuchal translucency (NT).
Quad Screen: A blood test that measures four substances associated with pregnancy and estimates the risk of certain chromosomal conditions.
Amniocentesis: A diagnostic test that analyses amniotic fluid to examine fetal chromosomes.
Chorionic Villus Sampling (CVS): A diagnostic test that examines placental tissue for chromosome abnormalities.
Karyotype Testing: Examines chromosomes to confirm an extra copy of chromosome 21.
After birth, a blood sample may be used for karyotype analysis to confirm the diagnosis.
How are the Tests Performed?
Preparation
Fasting is generally not required, unless you are having a PUBS test; then you may need to fast for several hours before the test.
For a CVS or amniocentesis, you may need to drink extra fluids and not urinate before the test.
Inform your healthcare provider about your pregnancy history and medical history.
Follow any specific instructions provided by your healthcare provider.
Collection
Maternal blood tests: Blood is collected from a vein in the pregnant person’s arm.
Cell-free DNA screening: A maternal blood sample is collected to analyze fetal DNA fragments circulating in the bloodstream.
Amniocentesis: A thin needle is guided through the abdomen to collect a small amount of amniotic fluid.
Chorionic Villus Sampling (CVS): A small sample of placental tissue is collected through the cervix or abdomen.
Newborn testing: A blood sample is collected from the baby’s vein or heel.
Lab Analysis
The sample is analyzed using specialized laboratory methods to identify chromosome abnormalities involving chromosome 21. Screening tests estimate the likelihood of Down syndrome, while diagnostic tests such as karyotype analysis can confirm the presence of an extra chromosome 21. Results are interpreted together with gestational age, ultrasound findings, medical history, and other test results.
What are the Symptoms that Prompt these Tests?
Down Syndrome Tests may be recommended during pregnancy when screening indicates an increased chance of Down syndrome or when ultrasound findings suggest a possible chromosomal abnormality.
Situations That May Prompt These Tests
Your healthcare provider may recommend Down Syndrome Tests if:
- Prenatal screening shows an increased chance of Down syndrome.
- An ultrasound shows findings associated with chromosomal abnormalities.
- The pregnant person is at increased risk based on age or medical history.
- There is a previous pregnancy or child with Down syndrome.
- There is a family history of certain chromosomal conditions.
- A newborn has physical features suggestive of Down syndrome.
- A healthcare provider needs to confirm a suspected diagnosis after birth.
Conditions That May Require These Tests
Down Syndrome Tests may be used to evaluate or confirm:
- Down syndrome (Trisomy 21)
- Other chromosome abnormalities
- Genetic conditions identified through prenatal screening
- Developmental or congenital conditions associated with chromosomal abnormalities
What are Normal Ranges for These Tests?
The Down Syndrome normal range depends on the specific screening or diagnostic test performed.
Screening Tests
Screening tests do not provide a simple positive or negative diagnosis. Results are generally reported as:
Screen Negative / Low Risk: The screening result indicates a lower chance of Down syndrome.
Screen Positive / High Risk: The screening result indicates an increased chance of Down syndrome and may require diagnostic testing.
The exact risk cutoff varies depending on the screening method and laboratory.
Diagnostic Tests
Diagnostic chromosome testing may report:
- Normal Karyotype: 46 chromosomes with no extra copy of chromosome 21 detected.
- Trisomy 21: An extra copy of chromosome 21 is present, confirming Down syndrome.
“The reference ranges vary depending on the laboratory and the methodology used. Individuals must consult their healthcare provider for correct interpretation of the results.”
What Happens if Test Results Show Abnormal Findings?
Abnormal Down Syndrome Test results may indicate an increased likelihood of Down syndrome or confirm the presence of an extra chromosome 21.
Positive or High-Risk Screening Results
A positive prenatal screening result does not confirm that the fetus has Down syndrome. It means there is an increased chance of the condition.
- Your healthcare provider may recommend:
- Genetic counselling
- Detailed ultrasound examination
- Amniocentesis
- Chorionic Villus Sampling (CVS)
- Diagnostic chromosome testing
If diagnostic testing confirms an extra copy of chromosome 21, the result is consistent with Down syndrome.
Down syndrome may be associated with:
- Developmental delays
- Intellectual disability
- Congenital heart defects
- Hearing problems
- Vision problems
- Thyroid disorders
- Sleep apnea
Increased risk of certain health conditions
The severity and combination of health concerns vary from person to person.
Negative or Low-Risk Results
A negative screening result indicates a lower chance of Down syndrome but does not eliminate the possibility. Screening tests cannot detect every case.
Depending on the results, your healthcare provider may recommend additional investigations such as Karyotype Genetic Testing, Chromosomal Microarray Analysis, Fluorescence In Situ Hybridization (FISH), or other genetic testing.
Need Down Syndrome Tests? Book your appointment today for reliable genetic screening and expert laboratory support.
